IP Library Patent Application 11357770
Patent Application
App. No. 11/357,770

Hemostatic compositions and methods for controlling bleeding

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/357,770
Abstract

The invention provides hemostatic compositions useful to promote hemostasis at active bleeding wound sites. The hemostatic compositions typically include an article containing cellulose, e.g., cotton gauze, and a polysaccharide covalently linked to the cellulose, or a polysaccharide ionically cross-linked and in association with the article. Methods of making and using the hemostatic compositions are also provided.

Claims (21)

1 . A method for controlling bleeding at an active bleeding wound site of an mammal, said method comprising applying a hemostatic composition to said active bleeding wound site, said hemostatic composition comprising an article comprising cellulose and a polysaccharide covalently linked to said cellulose.

2 . The method of claim 1 , wherein said polysaccharide is selected from the group consisting of dextran, starch, and alginate.

3 . The method of claim 2 , wherein said polysaccharide is dextran.

4 . The method of claim 3 , wherein said dextran is covalently cross-linked.

5 . The method of claim 3 , wherein the molecular weight of said dextran is from about 10,000 to about 2,000,000.

6 . The method of claim 5 , wherein the molecular weight of said dextran ranges from about 20,000 to about 100,000.

7 . The method of claim 1 , wherein said covalently linked polysaccharide has a molecular weight exclusion limit greater than about 30,000 Daltons.

8 . The method of claim 1 , wherein said article comprising cellulose is selected from the group consisting of a bandage, suture, dressing, gauze, gel, foam, web, film, tape, or patch.

9 . The method of claim 1 , wherein said article comprising cellulose comprises cotton.

10 . The method of claim 9 , wherein said article comprising cellulose is cotton gauze.

11 . The method of claim 1 , wherein prior to said application of said hemostatic composition, said active bleeding wound site bleeds at a rate from about 0.5 ml/min to about 1000 ml/min.

12 . The method of claim 11 , wherein after application of said hemostatic composition, said active bleeding wound site bleeds at a rate of less than 0.03 ml/min.

13 . The method of claim 12 , wherein said rate of less than 0.03 ml/min is achieved from about 2 to about 20 minutes after application of said bandage.

14 . The method of claim 1 , wherein said hemostatic composition further comprises a second polysaccharide covalently linked to said cellulose.

15 . The method of claim 6 , wherein said hemostatic composition further comprises a second polysaccharide, wherein said second polysaccharide is cross-linked dextran having a molecular weight from about 800,000 to about 2M, wherein said second polysaccharide is covalently linked to said cellulose.

16 . A method for controlling bleeding at an active bleeding wound site of an animal, said method comprising applying a hemostatic composition to said active bleeding wound site, said hemostatic composition comprising an article comprising cellulose in association with ionically cross-linked alginate.

17 . The method according to claim 16 , wherein said alginate is ionically cross-linked with a cation selected from the group consisting of: Mg2+; Ni2+; Ca2+; Sr2+; Ba2+; Zn2+; Cd2+; Cu2+; Pb2+; Fe3+; and Al3+.

18 . The method according to claim 16 , further comprising a second polysaccharide covalently linked to said cellulose, wherein said second polysaccharide is cross-linked dextran.

19 . The method according to claim 18 , wherein said alginate is further covalently linked to said cross-linked dextran.

20 . The method of claim 1 , wherein said mammal is a human.

21 . The method of claim 4 , wherein said covalently cross-linked dextran is in the form of beads.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2012
From: THEIS, JEROLD, DR.
To: LIGHTY, CRAIG E.
Reel/Frame 028434/0986 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2009
From: CROSSLINK-D, INC.
To: INTERNATIONAL MANUFACTURING GROUP, INC.; THEIS, JEROLD
Reel/Frame 022831/0529 →